Association of intronic variants of the BTBD9 gene with Tourette syndrome

Archives of Neurology

Volumn 66, Issue 10, 2009, Pages 1267-1272

  Rivière, Jean Baptiste ^a   Xiong, Lan ^a   Levchenko, Anastasia ^a   St Onge, Judith ^a   Gaspar, Claudia ^a   Dion, Yves ^a   Lespérance, Paul ^a   Tellier, Geneviève ^a   Richer, François ^a   Chouinard, Sylvain ^a   Rouleau, Guy A ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; BTBD9 GENE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MAP2K5 GENE; MEIS1 GENE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ADULT; ALLELE; CANADA; CASE CONTROL STUDY; CHILD; FAMILY; FEMALE; GENETICS; GENOTYPE; INTRON; MALE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PARASOMNIA; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT;

BTBD9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CANADA; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; FAMILY; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INTRONS; MALE; NEUROPSYCHOLOGICAL TESTS; NOCTURNAL MYOCLONUS SYNDROME; OBSESSIVE-COMPULSIVE DISORDER; OUTCOME ASSESSMENT (HEALTH CARE); POLYMORPHISM, SINGLE NUCLEOTIDE; RESTLESS LEGS SYNDROME; RISK ASSESSMENT; TOURETTE SYNDROME; TRANSCRIPTION FACTORS;

EID: 70350482910     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.213     Document Type: Article

References (30)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J; Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health; International Restless Legs Syndrome Study Grou Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-119.
2. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286-1292. (Pubitemid 40989594)
3. Hornyak M, Feige B, Riemann D, Voderholzer U. Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment. Sleep Med Rev. 2006;10(3):169-177. (Pubitemid 44177433)
4. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespérance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61-65. (Pubitemid 27032881)
5. Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol. 1993;50(10):1013-1016.
6. Peterson BS, Pine DS, Cohen P, Brook JS. Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry. 2001;40(6):685-695. (Pubitemid 32473383)
7. Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 2000;123(pt 3):425-462. (Pubitemid 30099531)
8. Lespérance P, Djerroud N, Diaz Anzaldua A, Rouleau GA, Chouinard S, Richer F; Montréal Tourette Study Group. Restless legs in Tourette syndrome. Mov Disord. 2004;19(9):1084-1087.
9. Lipinski JF, Sallee FR, Jackson C, Sethuraman G. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Mov Disord. 1997;12(3):402-407. (Pubitemid 27216140)
10. Singer HS. Current issues in Tourette syndrome. Mov Disord. 2000;15(6):1051-1063.
11. 11C-raclopride PET studies. Neurology. 1999;52(5):932-937.
12. Bliss J. Sensory experiences of Gilles de la Tourette syndrome. Arch Gen Psychiatry. 1980;37(12):1343-1347. (Pubitemid 11204072)
13. Prado HS, Rosario MC, Lee J, Hounie AG, Shavitt RG, Miguel EC. Sensory phenomena in obsessive-compulsive disorder and tic disorders: a review of the literature. CNS Spectr. 2008;13(5):425-432. (Pubitemid 351792225)
14. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000-1006. (Pubitemid 47185185)
15. Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357(7):639-647. (Pubitemid 47267233)
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
17. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011. (Pubitemid 19278229)
18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265. (Pubitemid 40202029)
19. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225-2229. (Pubitemid 34680308)
20. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity. 2005;95(3):221-227. (Pubitemid 43093236)
21. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-678.
22. Wolf N, Quaranta M, Prescott NJ, et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet. 2008;45(2):114-116. (Pubitemid 351252875)
23. Zeggini E, Weedon MN, Lindgren CM, et al; Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes [published correction appears in Science. 2007;317(5841):1035-1036]. Science. 2007;316(5829):1336-1341.
24. Cath DC, Spinhoven P, Hoogduin CA, et al. Repetitive behaviors in Tourette's syndrome and OCD with and without tics: what are the differences? Psychiatry Res. 2001;101(2):171-185. (Pubitemid 32245800)
25. Cath DC, Spinhoven P, van Woerkom TC, et al. Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate? J Nerv Ment Dis. 2001;189(4):219-228. (Pubitemid 32374289)
26. Coffey BJ, Miguel EC, Biederman J, et al. Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis. 1998;186(4):201-206. (Pubitemid 28169763)
27. Como PG, LaMarsh J, O'Brien KA. Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol. 2005;96:249-261.
28. Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet. 1999;88(1):38-43. (Pubitemid 29075319)
29. McMahon WM, van de Wetering BJ, Filloux F, Betit K, Coon H, Leppert M. Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree. J Am Acad Child Adolesc Psychiatry. 1996;35(5):672-680. (Pubitemid 26134806)
30. Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O. Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet. 1996;59(3):684-693. (Pubitemid 26269047)